The title molecule, C16H14O3, is slightly distorted from planarity, the dihedral angle between the two benzene rings being 9.51 (7)°. The configuration of the keto group with respect to the olefinic double bond is s‐cis. O—H⋯O hydrogen bonds, and C—H⋯O and π–π interactions, link the molecules to form a three‐dimensional network. The C—H⋯O interactions form rings of graph‐set motifs S(5), (6) and (7).
The title molecule, C15H11BrO2, is approximately planar and the dihedral angle between the two aromatic rings is 10.2 (2)°. The H atoms of the central enone moiety are trans. The molecules form centrosymmetric hydrogen‐bonded dimers via intermolecular O—H⋯O hydrogen bonds (H⋯O = 2.02 Å and O—H⋯O = 172 °).
Key indicatorsSingle-crystal X-ray study T = 293 K Mean (C-C) = 0.003 Å Disorder in main residue R factor = 0.055 wR factor = 0.169 Data-to-parameter ratio = 12.6For details of how these key indicators were automatically derived from the article, see
The title molecule, C15H12BrNO, is approximately planar and the dihedral angle between the two aromatic rings is 9.6 (1)°. The crystal packing reveals that the molecules translated by one unit cell along the a‐axis direction are linked into a chain by intermolecular N—H⋯O and C—H⋯O hydrogen‐bonding interactions. The screw‐related molecules of adjacent chains are linked via N—H⋯N hydrogen bonds into a sheet‐like structure parallel to the ab plane.
Key indicatorsSingle-crystal X-ray study T = 100 K Mean (C-C) = 0.002 Å R factor = 0.035 wR factor = 0.096 Data-to-parameter ratio = 32.7For details of how these key indicators were automatically derived from the article, see
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.